Skip to content
value.today
Benitec Biopharma Inc. logo

Benitec Biopharma Inc.

🇺🇸 Hayward, California, USABiotechnologyFounded 2019

Benitec Biopharma Inc. is listed today as Benitec Biopharma Inc.: market value, financials and filings are on its company page.

Funding rounds

0 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Benitec Biopharma Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2024$40 MPrivate placement after listing$10 to $50 million

Benitec Biopharma Inc.: Private sale, Apr 2024

Investors in this round

17 investors had bought by the notice of Apr 25, 2024: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$40 M of $40 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$2,400,001
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jerel Banks · Executive Officer, Director
  • Megan Boston · Executive Officer, Director
  • Edward Kevin Smith · Director
  • J. Kevin Buchi · Director
  • Peter Kevin Francis · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Leerink Partners LLC (CRD 39011) · Boston, MassachusettsSold in all US states
  • Citizens JMP Securities, LLC (CRD 22208) · San Francisco, CaliforniaSold in all US states

Signed by Jerel Banks, Chief Executive Officer and Chairman of the Board. Source: SEC Form D, newest notice filed Apr 25, 2024. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Benitec Biopharma Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2024).

    SEC Form D · Apr 2024

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Apr 2024

That is all the official record says: Benitec Biopharma Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services of Benitec Biopharma Inc. are on record.

Investors#

No investor of Benitec Biopharma Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete.

Largest shareholders today

Institutions holding Benitec Biopharma Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Benitec Biopharma Inc.
NameRoleNamed in
Jerel BanksExecutive officerApr 2024
Megan BostonExecutive officerApr 2024
Edward Kevin SmithDirectorApr 2024
J. Kevin BuchiDirectorApr 2024
Jerel BanksDirectorApr 2024
Megan BostonDirectorApr 2024
Peter Kevin FrancisDirectorApr 2024

Went public since 2015. Its SEC number is that of a company listed on a stock exchange.